42
Views
0
CrossRef citations to date
0
Altmetric
Review

Evaluation of the drug treatment regimens for pulmonary tuberculosis and their cost-effectiveness

&
Pages 43-48 | Published online: 24 Feb 2005

Bibliography

  • BETHEL LM: Cost-effectiveness considerations in finding appropriate chemotherapy treatments for bacterial diseases in developing countries: the case of tuberculosis. Univ. St Andrews (1995):17.
  • COHEN D: The impact of health economics on health policy, health services and decision-making. In: Pharmacoeconomics and Outcome Assessment - A Global Issue. Salek S (Ed.), Euromed Communications, Haslemere (1999):1–17.
  • MURRAY CJ, DEJONGHE E, CHUM HJ et al.:Cost-effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet (1991) 338(8778):1305–1308.
  • DE JONGHE E, MURRAY CJ, CHUM HJ et al.:Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Int. J. Health Plan. Manag. (1994) 9(2):151–181.
  • KAMOLRATANAKUL P, CHUNHASWASDISKUL B et al:Cost-effectiveness analysis of three short-course anti-tuberculosis programmes compared with a standard regimen in Thailand. J. Clin. Epidemiol (1993) 46(7)631–636.
  • JOESOEF MR, REMINGTON PL, JIPTOHERIJANTO PT: Epidemiological model and cost-effectiveness analysis of tuberculosis treatment programmes in Indonesia. Int. J. Epidemiol (1989) 18(0:174–179.
  • FRYATT RJ: Review of published cost-effectiveness studies on tuberculosis treatment programmes. Int. J. Tuberc. Lung Dis. (1997) 1(2):101–109.
  • ••Systematic review.
  • CASTELO A, MATHIASI PA, IUNES R et al.: Cost-effectiveness of antituberculosis interventions. PharmacoEconomics (1995) 8(5)385–399.
  • FLOYD K, WILKINSON D, GILKS C: Comparison of cost-effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. Br. Med. J. (1997) 315(7120):1407–1411.
  • VAN GORKOM J, KIBUGA DK: Cost-effectiveness and total costs of 3 alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of HIV positive patients with tuberculosis in Kenya. Tuber. Lung Dis. (1996) 77(0:30–36.
  • WORLD HEALTH ORGANIZATION: WHO report on the tuberculosis epidemic. (1995).
  • ZWARENSTEIN M, SCHOEMAN JH, VUNDULE C, LOMBARD CJ, TATLEY M: Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet (1998) 352:1340–1343.
  • GARNER P: What makes DOT work? Lancet (1998) 352:1326–1327.

Website

  • www.who.intigtbidots/index.htm World Health Organization Tuberculosis website (October 1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.